
A recent systematic review and meta-analysis examined the impact of surgical timing in patients with hip fractures receiving direct oral anticoagulants (DOACs). With DOAC use increasingly common, concerns about perioperative bleeding can contribute to delays in hip fracture surgery.
The review included six cohort studies involving 1,575 patients, comparing surgery performed within 24 hours of the last DOAC dose with surgery performed between 24 and 48 hours.
Key Findings
The findings suggest that, in appropriately selected patients, DOAC use alone may not justify routinely delaying hip fracture surgery. However, the evidence remains limited by the observational design of the included studies, potential confounding, and risk of bias. Further high-quality research is needed to establish the optimal timing of surgery in patients receiving DOAC therapy. The authors ultimately conclude that early surgery within 24 hours of the last DOAC dose can be supported in appropriately selected patients.
Read the article here.
© 2026 Global Fragility Fracture Network | All Rights Reserved I Designed by Aaron Knight